Dafna Capital Management LLC Liquidia Corp Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.51 - $3.11 $1.44 Million - $1.79 Million
-575,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.34 - $8.28 $108,500 - $206,999
25,000 Added 4.55%
575,000 $2.83 Million
Q2 2020

Aug 14, 2020
BUY
$4.86 - $11.44 $2.67 Million - $6.29 Million
550,000 New
550,000 $4.63 Million

Others Institutions Holding LQDA

# of Institutions
170
Shares Held
44.3M
Call Options Held
1.55M
Put Options Held
1.52M
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $940M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email